Ignacio Valero

Methodological-Technological Framework for Construction 4.0

Felipe Muñoz-La Rivera, Javier Mora Serrano, Ignacio Valero et al. · Archives of Computational Methods in Engineering · 2020 · 173 citations

Architecture, Civil Engineering, Construction Management +14

Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study

Alicia González-Baeza, Helen Dolengevich-Segal, Ignacio Valero et al. · AIDS Patient Care and STDs · 2018 · 133 citations · Full text

Medicine, Health Sciences, Preventive Medicine +14

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Jesús Rodríguez‐Baño, Jerónimo Pachón, Jordi Carratalà et al. · Clinical Microbiology and Infection · 2020 · 127 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde et al. · Clinical Infectious Diseases · 2017 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

Chloe Orkin, Jean‐Michel Molina, Eugènia Negredo et al. · The Lancet HIV · 2017 · 96 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17